Skip to main content
NIH Logo NIH Logo

Office of Research Services

Serving the NIH Community

Radiation Safety Committee

​​​​​​​​​​​The Radiation Safety Committee (RSC) formulates policy with regard to radiation protection matters in the Intramural Research Program to ensure compliance with Federal regulations, including those of the U.S. Nuclear Regulatory Commission. The Radioactive Drug Research Committee (RDRC) is a subcommittee of the NIH Radiation Safety Committee. The Radiation Safety Officer (RSO) is responsible to the NIH Director for management and operation of the Radiation Safety Program, as well as policy directives of the RSC.

The RSO and RSC provide​ sufficient authority, organizational freedom, and management prerogative to accomplish these goals. These responsibilities and authorities are limited to the NIH's Intramural Research Program and client agencies served under USNRC licenses 19-00296-10, 19-00296-17, and 19-00296-21. ​​​​​​​​​​​​​​​​​​​​



Duties of the Committee
Duties of the Committee

The RSC ensures the safe use of all radioactive materials and sources of radiation throughout NIH and  NIH-occupied buildings​.

learn more​

Membership & Organization
Membership & Organization

RSC membership is representative of the various types of users of radioactive materials and radiation sources at NIH.​​

learn more​

Clinical Authorized User Application
Clinical Authorized User Application

Physicians administering radiation in the form of radioactive materials (radiopharmaceuticals or sealed sources of radiation) must first apply for authorization through the RSC.

learn more

Clinical Protocol Information and Assistance
Clinical Protocol Information and Assistance

This site provides information to assist individuals in the preparation of clinical protocols that involve the use of ionizing radiation in human subjects through guidance documents, consent language templates, and informational pamphlets for research subjects and investigators.  ​

learn more

Radioactive Drug Research Committee
Radioactive Drug Research Committee
The Radioactive Drug Research Committee (RDRC)  reviews and approves the use of radioactive drugs for research purposes in humans for which an approved NDA (New Drug Application) or an approved INDA (Investigational New Drug Application) does not exist. 

learn more

Resources and References
Resources and References

View resources and references to facilitate the safe use of radioactive materials and all sources of ionizing radiation throughout NIH​​.

learn more​​​